delta-tocopherol has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosland, MC; Liu, A; Wang, G; Wang, H; Yang, CS; Yang, X | 1 |
| Barrera, SL; Dong, YQ; Forman, MR; Mahabir, S; Schendel, K; Spitz, MR | 1 |
2 other study(ies) available for delta-tocopherol and Adenocarcinoma
| Article | Year |
|---|---|
δ-Tocopherol inhibits the development of prostate adenocarcinoma in prostate specific Pten-/- mice.
Topics: Adenocarcinoma; Animals; Antioxidants; Cell Proliferation; Female; Male; Mice; Mice, Knockout; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Tocopherols | 2018 |
Dietary alpha-, beta-, gamma- and delta-tocopherols in lung cancer risk.
Topics: Adenocarcinoma; Adult; Aged; alpha-Tocopherol; Antioxidants; beta-Tocopherol; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Case-Control Studies; Dietary Supplements; Female; gamma-Tocopherol; Humans; Logistic Models; Lung Neoplasms; Male; Middle Aged; Odds Ratio; Risk Assessment; Risk Factors; Tocopherols; United States | 2008 |